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Lansbury and Caughey state in their
Primer on prion proteins [1] “Mice
lacking the PrP gene, first produced
by Charles Weissmann and
colleagues, are viable, but have
altered neuronal function and develop
neurological abnormalities later in
life.” This statement is misleading. 
The PrP-knockout mice produced
in our laboratory [2] do not show
neurological abnormalities at any time
and we have never reported such an
effect. Moreover, no structural
neuronal abnormalities were found in
an independent line of PrP-knockout
mice generated by Manson et al. [3]. 
The phenomenon referred to by
Lansbury and Caughey was observed
only by Sakaguchi et al. [4] in a line of
mice in which not only the PrP
coding region but also part of the large
intron was deleted. It is not possible
to attribute the observed phenotype
to ablation of PrP because correction
of the phenotype through
introduction of a PrP-expressing
cDNA has not been carried out.
Electrophysiological changes were
reported [5,6] for two different lines
of PrP-null mice, ours and those of
Manson et al., but these were not
reflected in neurological deficits.
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Gazetteer
The Scripps Research
Institute
What is it famous for?  High-profile
research and creative fund-raising. It
has several times spotted a scientific
trend in the making or started one,
switching its major focus from
cellular to molecular immunology,
then to structural biology, with
impeccable timing. The newest
focus seems to be ‘chemical biology’.
How did it start?  In 1924, the Scripps
Metabolic Clinic was founded in
downtown La Jolla, near San Diego,
California, by philanthropist Ellen
Browning Scripps. (She also founded
the independent Scripps
Oceanographic Institute.) She
stipulated in her will that research
should be one of the Clinic’s primary
activities, but until the 1950s the
research program was very small. 
When did research get going?  In
1956, the Clinic was renamed the
Scripps Clinic and Research
Foundation (SCRF), and in 1961,
five immunologists from Pittsburgh,
led by Frank Dixon, moved to
Scripps to found the Department of
Experimental Pathology.
What drew Dixon and colleagues to
Scripps?  At the time, San Diego was
not an attractive location for research,
being a small, ‘unprogressive’ town
dominated by retired naval officers.
(Nowadays, visitors to San Diego are
more likely to be put off by its size
and a horrendous sprawl of apartment
buildings.) Two factors seem to have
been crucial in Dixon’s decision to go
West: the option to pursue full-time
research with no clinical duties, and
generous NIH funding. 
Why did the SCRF move from
downtown La Jolla?  By 1969, the
growing Clinic had an acute space
problem. The scientific program
filled the old labs, the new research
building, and a motley collection of
buildings nearby — including beach
cottages, garages and a motel. In
1971 the Dow Chemical Company
came to the rescue, giving Scripps a
13.2-acre site on the Torrey Pines
mesa, five miles north of La Jolla. In
1977, the various research programs
came together under the umbrella of
the ‘Research Institute of Scripps
Clinic’, with Dixon as Director.
When did Dixon step down?  In 1987,
passing the baton to Richard Lerner,
then head of the Molecular Biology
Program. Lerner is now President,
and each department’s Chairman is
responsible for its scientific direction. 
Do links with industry continue?  Yes.
In 1981, the Institute began an
arrangement with Johnson & Johnson
that gave the company an option on
licensing Institute discoveries related
to human healthcare. Later, a very
similar deal with Sandoz was sharply
criticized for selling work supported
by NIH to a foreign company. And a
deal with PPG Industries allowed the
Molecular Biology building to expand
and a plant molecular biology
program to begin.
Is it still growing?  Yes. The most
recent addition is the Skaggs Institute
for Chemical Biology, to be headed by
Julius Rebek, made possible by a
$100 million commitment from the
Skaggs family (who run Safeway).
Why so many industry deals?  The
Institute is one of the largest, private,
non-profit institutes in the USA, but
has an endowment of only $55
million. Without industry money, the
infrastructure would be far less superb.
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